Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal of bringing genetic medicines to every patient in need.
Kelonia Therapeutics Address
N/A Boston, MA United States
Kelonia Therapeutics Email
Past Companies
Kelonia TherapeuticsSenior Director, Bioanalytical Development
Sana Biotechnology, Inc.Director, Bioanalytical Sciences